Fesoterodine Fumarate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 14 USDMF, 3 EU WC, 4 KDMF, 7 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers, 28 FDA Orange Book, 56 Europe, 4 Canada, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 4MG, TABLET, EXTENDED RELEASE;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 4 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 18 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 21 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 27 Controlled & Modified Release, 20 Direct Compression, 20 Thickeners and Stabilizers, 20 Granulation, 12 Topical, 12 Solubilizers, 11 Lubricants & Glidants, 10 Co-Processed Excipients, 10 Disintegrants & Superdisintegrants, 9 Taste Masking, 8 Chewable & Orodispersible Aids, 7 Rheology Modifiers, 7 Film Formers & Plasticizers, 5 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Emulsifying Agents

DIGITAL CONTENT

22 News #PharmaBuzz

22 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 30 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

3 APIs, 1 Intermediates

PATENTS & EXCLUSIVITIES

12 US Patents, 8 Health Canada Patents

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22030 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 4MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
FESOTERODINE FUMARATE(UNII: EOS72165S7) (FESOTERODINE - UNII:621G617227)	FESOTERODINE FUMARATE	8mg \| 4mg

Inactive Ingredients

Ingredient Name	Cardinal Health
ALUMINUM OXIDE(LMI26O6933)
GLYCERYL DIBEHENATE(R8WTH25YS2)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
INDIGOTINDISULFONATE SODIUM(D3741U8K7L)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
LECITHIN, SOYBEAN(1DI56QDM62)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
XYLITOL(VCQ006KQ1E)

Drug Product Composition: Fesoterodine Fumarate